Effects of HBV Genetic Variability on RNAi Strategies

Abstract EN

RNAi strategies present promising antiviral strategies against HBV.

RNAi strategies require base pairing between short RNAi effectors and targets in the HBV pregenome or other RNAs.

Natural variation in HBV genotypes, quasispecies variation, or mutations selected by the RNAi strategy could potentially make these strategies less effective.

However, current and proposed antiviral strategies against HBV are being, or could be, designed to avoid this.

This would involve simultaneous targeting of multiple regions of the genome, or regions in which variation or mutation is not tolerated.

RNAi strategies against single genotypes or against variable regions of the genome would need to have significant other advantages to be part of robust therapies.